International Biomedical Devices, Inc. (IBMD) is an early-stage medical device company specializing in ophthalmology innovations. Headquartered in Charleston, SC, IBMD is pioneering the emerging, non-laser-based precision capsulotomy category. This technology aims to significantly improve traditional cataract surgery techniques by offering safer, more precise procedures and more predictable outcomes for patients. The company's primary clients include ophthalmologists and eye surgery centers seeking advanced solutions for cataract treatment. Operating within the medical device market, IBMD's business model focuses on the development, commercialization, and sale of its proprietary capsulotomy technology. Revenue is generated through the sale of these devices and potentially through licensing agreements. Recently, IBMD secured $2.0 million in Series Seed preferred stock funding to support product development and clinical studies of its flagship product, the Precision Capsulotomy device.

Keywords: ophthalmology, capsulotomy, cataract surgery, medical devices, innovation, precision technology, non-laser, patient safety, product development, commercialization.